Loading...
Loading...
2 mins read
Researchers from universities in Texas tested an innovative technique on patients with post-traumatic stress disorder (PTSD) who did not respond to conventional treatments. The approach combines medical technology and psychotherapy to reconfigure the brain’s emotional responses. After 12 sessions, all participants no longer met the diagnostic criteria for PTSD, opening a promising path toward definitive recovery from this chronic condition.
Researchers from the University of Texas at Dallas and the Baylor University Medical Center have developed a method that has eliminated the symptoms of post-traumatic stress disorder (PTSD) in a group of patients previously considered resistant to standard therapy. The results were published on March 15 in the journal Brain Stimulation.
Phase 1 of the study involved applying Prolonged Exposure Therapy (PE)—a standard component of PTSD treatment—in a safe environment. This therapy consists of patients gradually confronting thoughts, memories, or situations associated with their trauma. It was combined with brief pulses that stimulated the vagus nerve, delivered through a device implanted in the patient's neck (VNS).
The vagus nerve is the main channel of the parasympathetic nervous system, responsible for involuntary functions such as heart rate, digestion, the immune system, and even mood regulation. It extends from the brainstem to the large intestine and has already been the focus of stimulation therapies to treat conditions such as epilepsy, depression, and rheumatoid arthritis.
This treatment was applied to nine patients over the course of 12 sessions. After completing the treatment, they were evaluated four times over a six-month period. During that time, all participants remained free of PTSD symptoms—a condition that, in most cases, is considered chronic. In standardized treatments, it is common for some patients to improve but still retain the PTSD diagnosis. In this clinical trial, 100% of participants no longer met the diagnostic criteria.
The new approach integrates PE therapy, which gradually exposes the patient to traumatic memories in a safe environment, allowing the brain to reconfigure its emotional responses, with vagus nerve stimulation, administered in parallel through a fully wireless, coin-sized implanted device.
According to the researchers, the key to success lies in this synergy: while PE therapy signals to the brain which associations should be weakened (for example, fear linked to a memory), vagal stimulation provides the necessary chemical environment—releasing neuromodulators such as acetylcholine and norepinephrine—for that reconfiguration to occur more effectively and durably.
This breakthrough builds on more than a decade of prior research that had already shown vagal stimulation accelerates motor rehabilitation after a stroke. The U.S. Food and Drug Administration (FDA) approved its use in that context in 2021. The device also represents a technological innovation: being small, affordable, and wireless, its implementation could facilitate broader access to treatment in the future.
Currently, the team is developing a Phase 2 placebo-controlled pilot study. The goal is to strengthen clinical evidence and pave the way for regulatory approval by the FDA. The project is funded by the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense.
Beyond pharmacological therapies and new strategies such as the use of psychedelics, video games, or mindfulness, this combination of medical technology and psychological therapy offers real hope for those who have lost faith in traditional treatments. What once seemed like a lifelong diagnosis may now have a way out.
Sources